1,096 results on '"Fazio, Nicola"'
Search Results
2. Radio-Guided Surgery with a New-Generation β-Probe for Radiolabeled Somatostatin Analog, in Patients with Small Intestinal Neuroendocrine Tumors
3. Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis
4. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
5. ASO Visual Abstract: Radio-Guided Surgery with a New-Generation β-Probe for Radio-Labeled Somatostatin Analog for Patients with Small-Intestinal Neuroendocrine Tumors
6. ASO Author Reflections: Radio-Guided Surgery in Small Intestine Neuroendocrine Tumors: New Probe, New Perspectives?
7. Diagnosis and staging of small intestinal neuroendocrine tumors with CT enterography and PET with Gallium-68: preoperative risk stratification protocol
8. Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group
9. Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy
10. Comparison of Khorana vs. ONKOTEV predictive score to individualize anticoagulant prophylaxis in outpatients with cancer
11. Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors
12. Differences in the molecular organisation of tumours along the colon are linked to interactions within the tumour ecosystem
13. Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial
14. Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data
15. Intra-individual variability in the neuroprotective and promyelinating properties of conditioned culture medium obtained from human adipose mesenchymal stromal cells
16. The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review
17. Efficacy and safety of systemic chemotherapy for radically resectable esophago-gastric adenocarcinoma in older patients: A systematic review and meta-analysis
18. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
19. Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: Where are we in 2023?
20. Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?
21. Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours
22. Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors
23. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
24. Conclusions: NEN Management Today and Looking at the Future
25. Mixed Neuroendocrine and Non-neuroendocrine Neoplasms (Mi NEN)
26. New Approaches in Medical Therapies
27. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?
28. Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer
29. Corrigendum to “Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours” [Eur J Cancer 188 (2023) 39–48]
30. Capacity to Consent in Healthcare: A Systematic Review and Meta-Analysis Comparing Patients with Bipolar Disorder and Schizophrenia Spectrum Disorder
31. Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside
32. Author Correction: GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome
33. GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome
34. Neuroendocrine Neoplasms (NENs)
35. The Right to Oncological Oblivion: A Legislative Response to Cancer Survivor Discrimination in Italy.
36. Pneumonectomy for broncho-pulmonary carcinoids: a single centre analysis of surgical approaches and patient outcomes.
37. Reliability of clinical judgment for evaluation of informed consent in mental health settings and the validation of the Evaluation of Informed Consent to Treatment (EICT) scale
38. Oxidative Stress in Sepsis: A Focus on Cardiac Pathology
39. Venous thromboembolism in pancreatic neuroendocrine neoplasm: a cohort study
40. Risk Management and Patient Safety in the Artificial Intelligence Era: A Systematic Review
41. Telehealth Intervention: A Proposal for a Telemedicine Manual to Ascertain the Civil Disability Status in Italy
42. Traumatic Aneurysm Involving the Posterior Communicating Artery
43. Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
44. Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis
45. Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib
46. Capacity to Consent in Healthcare: A Systematic Review and Meta-Analysis Comparing Patients with Bipolar Disorders and Schizophrenia Spectrum Disorders.
47. Discussing motherhood when the oncological prognosis is dire: ethical considerations for physicians
48. Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group
49. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
50. Fourteen Deaths from Suspected Heparin Overdose in an Italian Primary-Level Hospital
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.